Sanofi Stock Price and Value Analysis

Should you buy Sanofi stock? (NYSE:SNY). Let's see how it does in our automated value investing analysis system.

SNY Free Cash Flow Trend

Free Cash Flow trendline for SNY
Free Cash Flow trendline for Sanofi

Hmm, we can't give any reliable projection for Sanofi's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has fluctuating growth.
  • This company has a large dividend yield!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.

Inside the SNY Numbers

SNY Price
(Sanofi stock price per share)
[?] PE Ratio versus Sector 8% higher than other Healthcare stocks
[?] PE Ratio versus Industry 27% higher than other Drug Manufacturers - Major stocks
[?] Cash Yield 10.63%
[?] Free Cash Flow Jitter 32%
[?] Dividend Yield 4%

Is Sanofi Stock on Sale?

Based on our analysis, we believe that you should not buy Sanofi right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy SNY Stock?

Does Sanofi have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.